Literature DB >> 8454852

Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.

N Shastri1, F Gonzalez.   

Abstract

Peptide fragments are displayed on the APC surface by MHC class I molecules as ligands for appropriate TCR. Sequence analysis of MHC-bound peptide mixtures has suggested that naturally processed peptides are defined by their length and by the presence of MHC allele-defined consensus motifs. To define the minimal OVA peptide presented by Kb MHC, and the requirements for generation of endogenous OVA/Kb complex, APC were transfected with OVA cDNA constructs. We show that optimal stimulation of OVA/Kb-specific B3Z T cell hybrid by Kb-APC requires the OVA257-264 peptide (SIINFEKL, SL8) whether added exogenously, or when synthesized endogenously as precursor polypeptides. Thus, all information necessary for expression of the OVA/Kb complex is contained within the Kb octapeptide motif shared by SL8. Unexpectedly, the SL8/Kb or the influenza NP/Db complexes were also generated in APC even when the peptide coding sequences were placed in incorrect translational reading frames. By contrast, identical manipulations of the translational reading frame of the lacZ reporter gene reduced protein synthesis to undetectable levels demonstrating the remarkable efficiency with which endogenous peptide/MHC are generated in and presented by APC to T cells. These characteristics of the endogenous presentation may explain how large numbers of distinct peptide/MHC complexes are displayed on the cell surface and surveyed by TCR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454852

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Essential role of CD91 in re-presentation of gp96-chaperoned peptides.

Authors:  Robert J Binder; Pramod K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

3.  TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.

Authors:  Mitsuhiro Iyori; Tong Zhang; Haddon Pantel; Bethany A Gagne; Charles L Sentman
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

4.  Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.

Authors:  Tong Zhang; Charles L Sentman
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

5.  Polymer blend particles with defined compositions for targeting antigen to both class I and II antigen presentation pathways.

Authors:  Kenny K Tran; Xi Zhan; Hong Shen
Journal:  Adv Healthc Mater       Date:  2013-10-02       Impact factor: 9.933

6.  Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway.

Authors:  Sébastien Apcher; Guy Millot; Chrysoula Daskalogianni; Alexander Scherl; Bénédicte Manoury; Robin Fåhraeus
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

7.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

8.  The GTPase Rab3b/3c-positive recycling vesicles are involved in cross-presentation in dendritic cells.

Authors:  Liyun Zou; Jingran Zhou; Jinyu Zhang; Jingyi Li; Na Liu; Linlin Chai; Na Li; Ting Liu; Liqi Li; Zhunyi Xie; Hongli Liu; Ying Wan; Yuzhang Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

9.  Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Authors:  Florence Dzierszinski; Marion Pepper; Jason S Stumhofer; David F LaRosa; Emma H Wilson; Laurence A Turka; Sandra K Halonen; Christopher A Hunter; David S Roos
Journal:  Infect Immun       Date:  2007-09-10       Impact factor: 3.441

10.  Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.

Authors:  Michelle Nicole Messmer; Joshua Pasmowitz; Laura Elizabeth Kropp; Simon C Watkins; Robert Julian Binder
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.